MedWatch: Difference between revisions
CSV import |
CSV import |
||
| Line 25: | Line 25: | ||
[[Category:Medical and health organizations based in the United States]] | [[Category:Medical and health organizations based in the United States]] | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Medwatch-Logo.svg|MedWatch | |||
</gallery> | |||
<gallery> | <gallery> | ||
File:Medwatch-Logo.svg|MedWatch | File:Medwatch-Logo.svg|MedWatch | ||
</gallery> | </gallery> | ||
Revision as of 01:41, 20 February 2025
MedWatch is the United States Food and Drug Administration's (FDA) program for reporting serious reactions, product quality problems, therapeutic inequivalence, and product use errors with human medical products, including drugs, biologics, medical and radiation-emitting devices, and special nutritional products (e.g., medical foods, dietary supplements and infant formulas).
History
The MedWatch system was established in 1993 by the FDA under the direction of then Commissioner David A. Kessler. The program's purpose is to educate health care professionals and the public about the importance of reporting serious problems to FDA, and to make doing so as easy and convenient as possible.
Reporting
Health professionals are strongly encouraged to report adverse events via MedWatch. Patients can also report adverse events directly, either online, by mail, or by fax.
Impact
MedWatch reports have led to changes in product labeling, product recalls, and other FDA safety alerts. The program has been credited with identifying significant public health issues related to medical products.
See also
References
<references />


